[HTML][HTML] Targeting epigenetic regulators to overcome drug resistance in cancers

N Wang, T Ma, B Yu - Signal transduction and targeted therapy, 2023 - nature.com
Drug resistance is mainly responsible for cancer recurrence and poor prognosis. Epigenetic
regulation is a heritable change in gene expressions independent of nucleotide sequence …

[HTML][HTML] Polyphenols as potent epigenetics agents for cancer

P Rajendran, SA Abdelsalam, K Renu… - International journal of …, 2022 - mdpi.com
Human diseases such as cancer can be caused by aberrant epigenetic regulation.
Polyphenols play a major role in mammalian epigenome regulation through mechanisms …

The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications

P Icard, L Simula, L Fournel, K Leroy, A Lupo… - Drug Resistance …, 2022 - Elsevier
NSCLC is the leading cause of cancer mortality and represents a major challenge in cancer
therapy. Intrinsic and acquired anticancer drug resistance are promoted by hypoxia and HIF …

Functional correlation of genome‐wide DNA methylation profiles in genetic neurodevelopmental disorders

MA Levy, R Relator, H McConkey… - Human …, 2022 - Wiley Online Library
An expanding range of genetic syndromes are characterized by genome‐wide disruptions in
DNA methylation profiles referred to as episignatures. Episignatures are distinct, highly …

[PDF][PDF] Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders

MA Levy, H McConkey, J Kerkhof… - Human Genetics and …, 2022 - cell.com
Overlapping clinical phenotypes and an expanding breadth and complexity of genomic
associations are a growing challenge in the diagnosis and clinical management of …

Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

S Chen, Y Zhao, S Liu, J Zhang, YG Assaraf… - Drug Resistance …, 2022 - Elsevier
Despite the rapid advancement in the introduction of new drugs for cancer therapy, the
frequent emergence of drug resistance leads to disease progression or tumor recurrence …

[HTML][HTML] A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors

S Park, E Silva, A Singhal, MR Kelly, K Licon… - Nature Cancer, 2024 - nature.com
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6is) have revolutionized breast cancer
therapy. However,< 50% of patients have an objective response, and nearly all patients …

Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer

RP Johnson, CK Ratnacaram, L Kumar, J Jose - Drug Resistance Updates, 2022 - Elsevier
Prostate cancer (PC) is the most prevalent male urogenital cancer worldwide. PC patients
presenting an advanced or metastatic cancer succumb to the disease, even after therapeutic …

[HTML][HTML] The role of histone protein acetylation in regulating endothelial function

Z Fang, X Wang, X Sun, W Hu, QR Miao - Frontiers in Cell and …, 2021 - frontiersin.org
Endothelial cell (EC), consisting of the innermost cellular layer of all types of vessels, is not
only a barrier composer but also performing multiple functions in physiological processes. It …

[HTML][HTML] Protein acetylation and related potential therapeutic strategies in kidney disease

X Li, J Yu, Y Dong, X Shen, R Hou, M Xie, J Wei… - Pharmacological …, 2023 - Elsevier
Kidney disease can be caused by various internal and external factors that have led to a
continual increase in global deaths. Current treatment methods can alleviate but do not …